Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Tole combines ultrasound and AI to improve motor neuron disease diagnosis, reducing reliance on invasive procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results